A Simply Wall St analysis suggests Innospec stock is 25% undervalued based on discounted cash flow projections. The assessment highlights the specialty chemicals firm's capacity upgrades and R&D spend
Innospec Inc stock reached a 52-week high of $100.48 following strong second-quarter 2026 financial results that exceeded analyst expectations. The company maintains a $2.47 billion market cap and has
Innospec Inc. financial estimates cover reported data and analyst projections for key financial statements and valuation metrics. The content emphasizes that the information is for reference and does
Innospec Inc. will announce its third-quarter 2026 financial results on November 3 following market close. The company reported an 11.8% year-over-year revenue increase to USD 491.40 million in the pr
Innospec Inc scheduled its Q3 2026 earnings release for November 3, following Q2 revenue growth of 11.8% to USD 491.4 million. Adjusted earnings exceeded consensus estimates, while the stock traded at
Innospec reported a strong Q2 2026 with 12% revenue growth to $491.4 million, driven by gains across Performance Chemicals, Fuel Specialties, and Oilfield Services. The company maintains a debt-free b
Allspring Global Investments reduced its beneficial ownership in Innospec Inc. to 4.7% per a recent SEC filing. As of September 30, 2026, the firm holds 1,161,421 shares while maintaining sole voting
Innospec Inc. Senior VP Ian McRobbie received 3,164 phantom stock shares per Form 4 filing, vesting in stages through October 2028 contingent on continued employment.
Innospec Inc submitted a Form 4 regulatory filing on October 5th, as reported by Investing.com, concerning insider trading activities for the specialty chemical firm.
Innospec Inc shares hit a 52-week high after reporting Q2 earnings of $1.27 per share and revenue of $491.4 million, both exceeding analyst expectations.
Innospec Inc., a global specialty chemicals provider, will report Q3 2026 earnings on November 3, 2026, followed by a conference call on November 4.
Innospec Inc. will release its third-quarter 2026 earnings results on November 3, 2026, followed by a conference call with executives on November 4.
Innospec Inc stock reached a new 52-week high of $100.48 after reporting Q2 2026 revenues of $491.4 million, surpassing analyst expectations with strong adjusted earnings per share.
Innospec Inc shares reached a 52-week high of $97.2 following better-than-expected Q2 2026 earnings with adjusted EPS of $1.27 and revenue of $491.4 million.
Innospec Inc reported a strong Q2 2026 earnings beat with adjusted EPS of $1.27 and revenue of $491.4 million, driving its stock near a 52-week high despite decreased operating cash flow.
Innospec Inc stock reached a 52-week high of $97.2 following Q2 2026 results that beat EPS and revenue projections. The company maintains strong financial health and has increased dividends for 12 con
Innospec Inc. reported Q1 and Q2 2024 earnings, beating EPS estimates but missing revenue targets, with stock trading at $98.11.
Innospec Inc (IOSP) maintains a long-term positive bias despite neutral near-term readings. AI models propose trading strategies including momentum breakouts and risk-hedging with a 26.9:1 risk-reward
Innospec Inc. shares reached a 52-week high of $95.07 following strong Q2 2026 financial results that surpassed earnings and revenue expectations.
Innospec Inc met Q2 2023 EPS expectations at €1.11 but missed revenue projections by €13.47 million, reporting €415.77 million with 2.74% YoY growth. Next earnings are scheduled for November 10, 2026.
Innospec reported strong first-half 2026 results with increased sales and net income, alongside ongoing share repurchase activities. Analysts suggest the stock may be 6% undervalued following these fi
Innospec Inc. reported strong Q2 2026 earnings and completed a $34.87 million share repurchase program. The company focuses on specialized chemicals earnings despite raw material volatility.
Innospec Inc reported Q1 2024 earnings with an EPS beat of $1.75 against consensus, while revenue of $500.20 million slightly missed expectations. The release includes access to the earnings call and
Innospec Inc. shares reached a 52-week high of $94.67 following strong Q2 2026 financial results that exceeded earnings and revenue expectations despite near-term supply constraints.
Innospec reported Q2 2026 sales of US$491.4 million, achieving a debt-free balance sheet that drove a 7.5% stock rise. While authorizing a US$75 million share repurchase, the company noted risks from
Innospec Inc. released its Q2 2026 earnings call presentation, reporting EPS of $1.27 and revenue of $491.40 million, surpassing analyst estimates.
Innospec Inc. reported second-quarter 2026 adjusted earnings of $1.27 per share and revenues of $491.4 million, surpassing consensus estimates. Growth was broad-based across its Performance Chemicals,
The Public Employees Retirement System of Ohio significantly reduced its stake in Innospec Inc. by 96.6% in Q1, even as the company reported strong quarterly earnings beating analyst estimates.
Janus Henderson Group PLC reduced its stake in Innospec Inc. by 11.7% in Q1, while other institutions increased positions. Innospec reported strong quarterly earnings with $1.27 EPS and 11.8% revenue
Innospec Inc reported strong Q2 2026 earnings with double-digit sales growth, despite margin pressures from supply constraints. Management plans facility expansions by late 2026 to boost capacity and
Innospec reported strong Q2 2026 financial results with revenue rising 12% to $491.4 million. Net income reached $30.8 million while maintaining a debt-free balance sheet and returning capital to shar
Innospec Inc stock reached a new 52-week high of $92.31 following strong Q2 2026 results that exceeded analyst expectations with $1.27 adjusted EPS. The company holds a $2.26 billion market cap, with
Innospec Inc exceeded Q2 2026 forecasts with adjusted EPS of $1.27 and revenue of $491.4 million, driving a 2.7% stock rise. Management highlighted double-digit segment growth and plans to boost Perfo
Innospec Inc. reported strong Q2 2026 results with revenue of $491.4 million and EPS of $1.25. Growth was driven by volume gains in Fuel Specialties and Performance Chemicals segments alongside operat
Innospec reported strong Q2 2026 earnings with 12% revenue growth to $491.4 million, while Performance Chemicals capacity is set to increase by over 10% following plant repairs.
Innospec Inc. reported strong second-quarter 2026 financial results, with revenues rising 12% to $491.4 million driven by Fuel Specialties and Performance Chemicals segments. The company maintained a
Innospec Inc has released its earnings summary for the quarter ended June 30. The full article is available through Refinitiv on TradingView for subscribers.
Innospec Inc. reported Q2 adjusted EPS of $1.27 and revenue of $491.4 million, both exceeding analyst estimates. These results indicate strong financial performance for the company in the second quart
Innospec Inc. shares declined 1.19% to $84.875 with a $2.10 billion market cap. Analysts maintain a 'Buy' rating with a $99.33 target price, citing strong fundamentals in the Chemicals industry.
Innospec Inc (IOSP) ranks 20th in the Chemicals industry with a financial score of 7.76. Quarterly revenue hit $453.20 million, up 2.81% YoY, while net profit increased by 7.32%.
Innospec Inc reports $134.40 million in total dividends over five years, providing a detailed timeline of payout dates and stock split events.
Innospec Inc details its major institutional shareholders including BlackRock and Vanguard, outlining shareholding trends and ETF holdings over recent quarters.
Innospec Inc publishes a detailed cash flow analysis breaking down operating, investing, and financing activities across various fiscal quarters. Key financial figures including net income and capital
Innospec Inc stock maintains gains backed by strong Q1 2024 earnings, including a 3.8% revenue increase and 10% rise in adjusted operating income. Resilient margins in fuel specialties and performance
Innospec Inc. posted stable fiscal 2023 results featuring modest revenue growth and improved operating cash flow. Performance chemicals sustained profitability, supporting consistent dividends and sha
Innospec Inc reported fiscal 2024 revenue of $1.8 billion, up 6%, driven by its Performance Chemicals segment. Adjusted EPS rose 11% to $5.20, reflecting disciplined capital allocation and strong cash
Innospec Inc shares trade below fair value following removal from Russell growth indices. The company maintains a strong cash position and focuses on specialty chemicals and battery chemistry markets.
Specialty chemicals maker Innospec Inc is identified as a potential acquisition target valued between $2.4 billion and $2.8 billion. Potential buyers such as NewMarket, SLB, and Ecolab are highlighted
Innospec Inc remains a Nasdaq-listed specialty chemicals firm focused on fuel additives and performance chemicals, linking operations to refinery activity and industrial end markets.
Innospec Inc. announced its Q2 2026 earnings release on August 4, followed by an investor conference call on August 5 at 10:00 a.m. ET. Registration is required for access to the audio webcast.
ChemBrief